BACKGROUND: Cerebrospinal fluid (CSF) analysis is often deferred in patients with cryptococcal disease, particularly in the absence of neurologic manifestations. We sought to determine whether a subset of solid organ transplant (SOT) recipients with high likelihood of central nervous system (CNS) disease could be identified in whom CSF analysis must be performed. METHODS: Patients comprised a multicenter cohort of SOT recipients with cryptococcosis. RESULTS: Of 129 (88%) of 146 SOT recipients with cryptococcosis who underwent CSF analysis, 80 (62%) had CNS disease. In the overall study population, abnormal mental status, time to onset of cryptococcosis more than 24 months posttransplantation (late-onset disease), serum cryptococcal antigen titer more than 1:64, and fungemia were independently associated with an increased risk of CNS disease. Of patients with abnormal mental status, 95% had CNS cryptococcosis. When only patients with normal mental status were considered, three predictors (serum antigen titer >1:64, fungemia, and late-onset disease) independently identified patients with CNS cryptococcosis; the risk of CNS disease was 14% if none, 39% if one, and 94% if two of the aforementioned predictors existed (chi for trend P<0.001). CONCLUSIONS: CSF analysis should be strongly considered in SOT recipients with cryptococcosis who have late-onset disease, fungemia, or serum cryptococcal antigen titer more than 1:64 even in the presence of normal mental status.
BACKGROUND: Cerebrospinal fluid (CSF) analysis is often deferred in patients with cryptococcal disease, particularly in the absence of neurologic manifestations. We sought to determine whether a subset of solid organ transplant (SOT) recipients with high likelihood of central nervous system (CNS) disease could be identified in whom CSF analysis must be performed. METHODS:Patients comprised a multicenter cohort of SOT recipients with cryptococcosis. RESULTS: Of 129 (88%) of 146 SOT recipients with cryptococcosis who underwent CSF analysis, 80 (62%) had CNS disease. In the overall study population, abnormal mental status, time to onset of cryptococcosis more than 24 months posttransplantation (late-onset disease), serum cryptococcal antigen titer more than 1:64, and fungemia were independently associated with an increased risk of CNS disease. Of patients with abnormal mental status, 95% had CNS cryptococcosis. When only patients with normal mental status were considered, three predictors (serum antigen titer >1:64, fungemia, and late-onset disease) independently identified patients with CNS cryptococcosis; the risk of CNS disease was 14% if none, 39% if one, and 94% if two of the aforementioned predictors existed (chi for trend P<0.001). CONCLUSIONS:CSF analysis should be strongly considered in SOT recipients with cryptococcosis who have late-onset disease, fungemia, or serum cryptococcal antigen titer more than 1:64 even in the presence of normal mental status.
Authors: Annemarie E Brouwer; Paprit Teparrukkul; Supraphada Pinpraphaporn; Robert A Larsen; Wirongrong Chierakul; Sharon Peacock; Nicholas Day; Nicholas J White; Thomas S Harrison Journal: J Infect Dis Date: 2005-07-07 Impact factor: 5.226
Authors: M S Saag; R J Graybill; R A Larsen; P G Pappas; J R Perfect; W G Powderly; J D Sobel; W E Dismukes Journal: Clin Infect Dis Date: 2000-04-20 Impact factor: 9.079
Authors: Nina Singh; Olivier Lortholary; Barbara D Alexander; Krishan L Gupta; George T John; Kenneth J Pursell; Patricia Muñoz; Goran B Klintmalm; Valentina Stosor; Ramon Del Busto; Ajit P Limaye; Jyoti Somani; Marshall Lyon; Sally Houston; Andrew A House; Timothy L Pruett; Susan Orloff; Atul Humar; Lorraine A Dowdy; Julia Garcia-Diaz; Andre C Kalil; Robert A Fisher; Joseph Heitman; Shahid Husain Journal: Transplantation Date: 2005-10-27 Impact factor: 4.939
Authors: S Ascioglu; J H Rex; B de Pauw; J E Bennett; J Bille; F Crokaert; D W Denning; J P Donnelly; J E Edwards; Z Erjavec; D Fiere; O Lortholary; J Maertens; J F Meis; T F Patterson; J Ritter; D Selleslag; P M Shah; D A Stevens; T J Walsh Journal: Clin Infect Dis Date: 2001-11-26 Impact factor: 9.079
Authors: Hsin-Yun Sun; Barbara D Alexander; Olivier Lortholary; Francoise Dromer; Graeme N Forrest; G Marshall Lyon; Jyoti Somani; Krishan L Gupta; Ramon del Busto; Timothy L Pruett; Costi D Sifri; Ajit P Limaye; George T John; Goran B Klintmalm; Kenneth Pursell; Valentina Stosor; Michelle I Morris; Lorraine A Dowdy; Patricia Munoz; Andre C Kalil; Julia Garcia-Diaz; Susan Orloff; Andrew A House; Sally Houston; Dannah Wray; Shirish Huprikar; Leonard B Johnson; Atul Humar; Raymund R Razonable; Shahid Husain; Nina Singh Journal: Clin Infect Dis Date: 2009-12-01 Impact factor: 9.079
Authors: Bahar H Kashef Hamadani; Carlos Franco-Paredes; Bruce McCollister; Leland Shapiro; J David Beckham; Andrés F Henao-Martínez Journal: Mycoses Date: 2018-01-23 Impact factor: 4.377
Authors: Andrés F Henao-Martínez; Lilyana Gross; Bryan Mcnair; Bruce McCollister; Kristen DeSanto; Jose G Montoya; Leland Shapiro; J David Beckham Journal: Mycopathologia Date: 2016-08-08 Impact factor: 2.574
Authors: Gustavo de Sousa Arantes Ferreira; Andre Luis Conde Watanabe; Natalia de Carvalho Trevizoli; Fernando Marcus Felippe Jorge; Carolina de Fatima Couto; Priscila Brizolla de Campos; Gabriel Oliveira Nunes Caja Journal: World J Hepatol Date: 2020-05-27